U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07563621) titled 'Determining the Extent of the Genitourinary Syndrome of Menopause Burden in Breast Cancer Survivors' on Feb. 09.
Brief Summary: Breast cancer survivors (BCS) often face unique challenges during and after treatment, including the onset of menopause-related symptoms. Genitourinary Syndrome of Menopause (GSM) is a common concern in BCS undergoing endocrine therapy (ET). It is a chronic condition caused by estrogen deficiency, leading to vaginal and urinary symptoms such as dryness, irritation, pain during intercourse, recurrent infections, and urinary urgency.
The prevalence of GSM in BCS varies widely depending on factors such as the t...